Literature DB >> 8079660

Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells.

R T Franceschi1, B S Iyer, Y Cui.   

Abstract

Treatment of mouse MC3T3-E1 cells with ascorbic acid initiates the formation of a collagenous extracellular matrix and synthesis of several osteoblast-related proteins. We recently showed that ascorbic acid dramatically increases alkaline phosphatase and osteocalcin mRNAs and that this induction is blocked by inhibitors of collagen triple-helix formation (Franceschi and Iyer, J Bone Miner Res 7:235). In the present study, the relationship between collagen matrix formation and osteoblast-specific gene expression is explored in greater detail. Kinetic studies revealed that ascorbic acid increased proline hydroxylation in the intracellular procollagen pool within 1 h and stimulated the cleavage of type I collagen propeptides beginning at 2.5 h. Mature alpha 1(I) and alpha 2(I) collagen components were first detected at 10 h and continued to increase in both cell layer and culture medium for up to 72 h. Ascorbic acid also increased the rate of procollagen secretion from cell layers to culture medium. The secretion of another matrix protein, fibronectin, was only slightly affected. Alkaline phosphatase or its mRNA was first detected 2-3 days after ascorbic acid addition, but osteocalcin mRNA was not seen until day 6. Two inhibitors of collagen triple-helix formation, ethyl-3,4-dihydroxybenzoate and 3,4-dehydroproline, inhibited procollagen hydroxylation and alkaline phosphatase induction. 3,4-Dehydroproline also inhibited the induction of alkaline phosphatase and osteocalcin mRNAs. Surprisingly, induction was not blocked if cells were exposed to ascorbic acid before inhibitor addition. Alkaline phosphatase was also partially inhibited if cells were grown in the presence of purified bacterial collagenase. These results indicate that the induction of osteoblast markers by ascorbic acid does not require the continuous hydroxylation and processing of procollagens and suggest that a stable, possibly matrix-associated signal is generated at early times after ascorbic acid addition that allows subsequent induction of osteoblast-related genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079660     DOI: 10.1002/jbmr.5650090610

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  95 in total

1.  E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the retinoblastoma protein.

Authors:  M Parreño; J Garriga; A Limón; X Mayol; G R Beck; E Moran; X Graña
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  The Roles and Mechanisms of Actions of Vitamin C in Bone: New Developments.

Authors:  Patrick Aghajanian; Susan Hall; Montri D Wongworawat; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2015-10-07       Impact factor: 6.741

Review 3.  Diverse biological functions of extracellular collagen processing enzymes.

Authors:  Philip C Trackman
Journal:  J Cell Biochem       Date:  2005-12-01       Impact factor: 4.429

4.  Collagen/annexin V interactions regulate chondrocyte mineralization.

Authors:  Hyon Jong Kim; Thorsten Kirsch
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

5.  Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.

Authors:  Zhaoyong Li; Mohammad Q Hassan; Mohammed Jafferji; Rami I Aqeilan; Ramiro Garzon; Carlo M Croce; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

6.  Craniosynostosis in transgenic mice overexpressing Nell-1.

Authors:  Xinli Zhang; Shun'ichi Kuroda; Dale Carpenter; Ichiro Nishimura; Chia Soo; Rex Moats; Keisuke Iida; Eric Wisner; Fei-Ya Hu; Steve Miao; Steve Beanes; Catherine Dang; Heleni Vastardis; Michael Longaker; Katsuyuki Tanizawa; Norihiro Kanayama; Naoaki Saito; Kang Ting
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  The vitamin C transporter SVCT2 is down-regulated during postnatal development of slow skeletal muscles.

Authors:  Daniel Sandoval; Jorge Ojeda; Marcela Low; Francisco Nualart; Sylvain Marcellini; Nelson Osses; Juan Pablo Henríquez
Journal:  Histochem Cell Biol       Date:  2013-01-18       Impact factor: 4.304

8.  Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions.

Authors:  Jinlu Dai; Honglai Zhang; Andreas Karatsinides; Jill M Keller; Kenneth M Kozloff; Dana T Aftab; Frauke Schimmoller; Evan T Keller
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

9.  Disease-associated extracellular matrix suppresses osteoblastic differentiation of human periodontal ligament cells via MMP-1.

Authors:  Jeena Joseph; Yvonne L Kapila; Takayuki Hayami; Sunil Kapila
Journal:  Calcif Tissue Int       Date:  2009-12-02       Impact factor: 4.333

10.  Sustained release of vitamin C from PCL coated TCP induces proliferation and differentiation of osteoblast cells and suppresses osteosarcoma cell growth.

Authors:  Susmita Bose; Naboneeta Sarkar; Sahar Vahabzadeh
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-08-16       Impact factor: 7.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.